(Q45221997)

11 December 2017

title

Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

2

1 reference

11 December 2017

1

Lauren L Jantzie

1 reference

11 December 2017

Kathryn G Todd

3

1 reference

11 December 2017

publication date

1 March 2005

1 reference

Journal of Cerebral Blood Flow & Metabolism

11 December 2017

published in

1 reference

11 December 2017

volume

25

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

314-324

1 reference

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Microglia as a source and target of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Neurobiology of hypoxic-ischemic injury in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Susceptibility to apoptosis is enhanced in immature cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Perinatal brain injury in the preterm and term newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Apoptosis and brain development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Cytokines and perinatal brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Microglia as neuroprotective, immunocompetent cells of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Hypoxic-ischemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Interventions for perinatal hypoxic-ischemic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

7 January 2021

Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

7 January 2021

The influence of immaturity on hypoxic‐ischemic brain damage in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

7 January 2021

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600025

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600025

1 reference

11 December 2017

1 reference